|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/09 | |
| A61P 31/18 | |||
| A61P 37/04 | |||
| A61P 5/08 | |||
| A61K 45/06 |
| (11) | Number of the document | 2307040 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09755128.7 |
| Date of filing the European patent application | 2009-05-18 | |
| (97) | Date of publication of the European application | 2011-04-13 |
| (45) | Date of publication and mention of the grant of the patent | 2015-09-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2009/000255 |
| Date | 2009-05-18 |
| (87) | Number | WO 2009/145690 |
| Date | 2009-12-03 |
| (30) | Number | Date | Country code |
| 0801255 | 2008-05-29 | SE |
| (72) |
LJUNGBLAD, Ulf, SE
BACKSTRĂ–M LUNDGREN, Yen, SE
WINQVIST, Ola, SE
|
| (73) |
Isr Immune System Regulation Ab,
Avd L2:04 Karolinska universitetssjukhuset Solna, 17176 Stockholm,
SE
|
| (54) | USE OF GNRH AND SEX HORMONES FOR TREATING VIRAL DISEASE, IN PARTICULAR HIV/AIDS |
| USE OF GNRH AND SEX HORMONES FOR TREATING VIRAL DISEASE, IN PARTICULAR HIV/AIDS |